alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1




                             CERTIFICATION
           PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Jianjun Zhang, certify that:

1.   I have reviewed this quarterly report on Form 10-QSB of Easton
Technologies Corp.;

2.   Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

      a)  Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

      b)  Evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures as of the end of the
period covered by this report based on such evaluation; and

      c)  Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of
an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

5.   The registrant's other certifying officer(s) and I have disclosed, based
on our most recent evaluation of the internal control over financial reporting,
to the registrant's auditors and the audit committee of the registrant's
board of directors (or persons performing the equivalent functions):

      a) All significant deficiencies and material weaknesses in the design or
operation of internal  controls over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

       b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.


Date:  July 23, 2004


/s/ Jianjun Zhang
---------------------------------------
Jianjun Zhang, President
(principal executive officer and principal
 accounting officer)
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Internal Revenue Service 

# AGENCY:

Internal Revenue Service, Treasury. 

# ACTION:

Notice. 

# SUMMARY:

Pursuant to 5 U.S.C. app. I section 10(d), of the Federal Advisory  Committee Act, and 5 U.S.C. section 552b, the Government in the Sunshine Act, a report summarizing the closed meeting activities of the Art Advisory Panel during 2008 has been prepared. A copy of this report has been filed with the Assistant  Secretary of the Treasury for Management. 

# DATES:

*Effective Date:*                         This notice is effective March 20, 2009.                     

# ADDRESSES:

                        The report is available for public inspection and requests for copies should be addressed to: Internal Revenue Service, Freedom of Information Reading  Room, Room 1621, 1111 Constitution Avenue, NW., Washington, DC 20224, telephone number (202) 622-5164 (not a toll free number). The report is also available at                         *http://www.irs.gov*.                     

# FOR FURTHER INFORMATION CONTACT:

Karen Carolan, AP:ART, Internal Revenue Service/Appeals, 1099 14th Street, NW., Washington, DC 20005, telephone (202) 435-5609 (not a toll free telephone number). 

# SUPPLEMENTARY INFORMATION:

The Commissioner of Internal Revenue has determined that this document is not a major rule as defined in Executive Order 12291 and that a regulatory impact analysis, therefore, is not required. Neither does this document constitute a rule subject to the Regulatory Flexibility Act (5 U.S.C. Chapter 6). 

Douglas H. Shulman, 

Commissioner of Internal Revenue. 

[FR Doc. E9-6062 Filed 3-19-09; 8:45 am] 

BILLING CODE 4830-01-P
Exhibit 32.1





CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of World Health Alternatives, Inc. (the Company) on Form 10-QSB for the period ending September 30, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the Report), I, Richard E, McDonald, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
Act of 2002, that:



(1) The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|                                                                                             
|---------------------------------------------------------------------------------------------
|                                                                                             
|/s/    RICHARD E.
MCDONALD                                                                   
|Richard E. McDonald President, Chief Executive Officer and Chairman of the Board of Directors
|                                                                                             
|November 22, 2004
### Michigan Supreme Court Lansing, Michigan

Marilyn Kelly,
Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk May 25, 2010

s0517 

# Order

May 25, 2010

140398

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

v SC: 140398 COA: 285563 Isabella CC: 07-002008-FC DANIEL LEE SLOCUM, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the December 10, 2009 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.
| 1.   | I have reviewed this amended annual report on Form 10-K of Freedom Environmental Services, Inc. ; |
|----------------|---------------------------------------------------------------------------------------------------|

| 2.   | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.   | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report; |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.   | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have: |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.   | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----
Exhibit
10.39


 


Description
of Director and Executive Compensation Arrangements


 


A.                      Non-Employee Director Compensation.


 


Annual Retainer for Service on
the Board:


 


·                  $60,000 payable in quarterly installments.


 


·                  Shares of restricted stock equal to $75,000 based upon the closing
price of our common stock on the NYSE on the date of the grant. Restricted
stock is granted in March of each year and vests over three years.


 


Annual Retainer for Chairman of
the Audit, Compensation and Nominating & Corporate Governance Committees - $25,000.


 


Annual Committee Membership Fees - $12,500 for each Committee (non-chair members).


 


Each grant of restricted stock is
made pursuant to the Company’s 2003 Equity Incentive Plan.  In addition, the Director Phantom Stock Plan
offers non-employee directors the opportunity to defer cash compensation for up
to three years and to receive that compensation (to the extent that it is
actually earned by service during that period) in shares of common stock rather
than in cash after termination of service or a predetermined period. Such
compensation includes the annual retainer, committee chair and committee membership
fees.


 

















 


B.                      Executive Officers.


 


The base salaries for the Company’s
executive officers who are named executive officers in the Company’s Proxy
Statement as of January 1, 2010 are as follows:


 


	
  Arthur M. Coppola, Chairman of the Board and Chief
  Executive Officer

  	
   

  	
  $

  	
  950,000

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Edward C. Coppola, President

  	
   

  	
  $

  	
  800,000

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Tony Grossi, Senior Executive Vice President,
  Chief Operating Officer and Chief Economist

  	
   

  	
  $

  	
  600,000

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Thomas E. O’Hern, Senior Executive Vice President,
  Chief Financial Officer and Treasurer

  	
   

  	
  $

  	
  550,000

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Richard A. Bayer, Senior Executive Vice President,
  Chief Legal Officer and Secretary

  	
   

  	
  $

  	
  500,000

  	
   

  



 


The
Company has an annual incentive compensation program for our executive officers
under which bonuses, which may be in the form of cash and/or equity awards, are
granted to reflect corporate and individual performance during the prior
calendar year. The actual bonus amounts granted are determined by the
Compensation Committee in its discretion based on its assessment of corporate
and individual performance for each executive officer.
Exhibit 32.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002



Pursuant to 18 U.S.C. Section 1350, the undersigned officer of
Medco Health Solutions, Inc. (the Company), hereby certifies, to the knowledge of the undersigned, that the Companys Quarterly Report on Form 10-Q for the quarter ended March 26, 2005 (the Report) fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                     |  |  |  |     |  |                        |  |                                                
|-------------------- |  |  |  | --- |  | ---------------------- |  | -----------------------------------------------
|                     |  |  | 
|Date: April 29, 2005 |  |  |  | By: |  | /s/ David B. Snow, Jr.
|                     |  |  |  |     |  | Name:                  |  | David B. Snow, Jr.                             
|                     |  |  |  |     |  | Title:                 |  | Chairman, President and Chief Executive Officer



This certification accompanies this
Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the Exchange Act). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically
incorporates it by reference.
Exhibit 10.13





Exhibit 10.13






The following current executive officers have entered into Executive Severance Agreements with
the Company in the form filed herewith. The information listed below is inserted into the blanks
for the respective executive officer’s Executive Severance Agreement.



	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	Change of Control
	 	 	Salary Multiplier	 	 	Termination	 	Continuation
	 	 	Rate	 	 	Period	 	Period
	 	 	(Section 4(a)(4))	 	 	(Section 1(a))	 	(Section 2)
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Blake W. Krueger
	 	 	3	 	 	3 years	 	36 months
	Kenneth A. Grady
	 	 	2	 	 	2 years	 	24 months
	Donald T. Grimes
	 	 	2	 	 	2 years	 	24 months
	Pamela L. Linton
	 	 	2	 	 	2 years	 	24 months
	Michael F. McBreen
	 	 	2	 	 	2 years	 	24 months
	James D. Zwiers
	 	 	2	 	 	2 years	 	24 months
Exhibit 32.2 - Chief Financial Officer Certification (Section 906)



                        CERTIFICATION PURSUANT TO
                         18 U.S.C. SECTION 1350,
                         AS ADOPTED PURSUANT TO
             SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of World Information Technology, Inc.
(the "Company") on Form 10-QSB for the period ending June 30, 2003 as filed
with the Securities and Exchange Commission on the date hereof (the "Report").
I, Steven D. Fellows, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that, to the best of my knowledge and belief:

        (1)   The Report fully complies with the requirements of
              section 13(a) or 15(d) of the Securities Exchange Act
              of 1934; and

        (2)   The information contained in the Report fairly presents,
              in all material respects, the financial condition and
              result of operations of the Company.


/s/ Steven D. Fellows
------------------------------
    Steven D. Fellows
    Chief Financial Officer


Date  August 18, 2003
      ---------------
<PAGE>

                                                                    EXHIBIT 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Noble Corporation (the
"Company") on Form 10-Q for the period ended June 30, 2003, as filed with the
United States Securities and Exchange Commission on the date hereof (the
"Report"), I, James C. Day, Chairman and Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.



August 13, 2003                             /s/  JAMES C. DAY
                                            ------------------------------------
                                            James C. Day
                                            Chairman and Chief Executive Officer
                                            of Noble Corporation
EXHIBIT 23.1





INDEPENDENT AUDITORS CONSENT





The Board of Directors


Bay View Capital Corporation:





We consent to the incorporation by reference in the registration statements (Nos. 33-30602, 33-30603, 33-36161,
33-41294, 33-95724, 33-95726, 333-37027, 333-37029, 333-37031, and 333-92637) on Form S-8 and in the registration statements (Nos. 333-29757 and 333-64877) on Form S-3 of Bay View Capital Corporation of our report dated February 14, 2001, relating
to the consolidated statements of financial condition of Bay View Capital Corporation and subsidiaries as of December 31, 2000 and 1999, and the related consolidated statements of operations and comprehensive income (loss), stockholders equity
and cash flows for each of the years in the three-year period ended December 31, 2000, which report appears in the December 31, 2000 Annual Report on Form 10-K of Bay View Capital Corporation.





/S
/    KPMG LLP





San Francisco, California


March 26, 2001
### SAT Report PMN Number: S-13-0049 SAT Date: 7/26/2013 Print Date: 12/6/2013

Related cases :

Concern levels : Type of Concern: Health Eco Comments Level of Concern: 1-2 1

Persistence Bioaccum Toxicity Comments 3 11

Exposure Based Review : Health: Yes Exposure based testing (health): INHALATION ONLY Ecotox: Yes
Routes of exposure : Health: Inhalation Ecotox: N o releases to water Fate: ;

P 2 Rec Comments : Comment: SAT has no comment at this time
Keywords : Keywords: LUNG OVERLOAD; MUTA; SENS-L; ONCO (UNCERT) Summary of Assessment :
Fate : Fate Summary: S-13-0049 FATE: Solid with MP = 1300-1350 C (M) S < 0.001 mg/L at 25 C (E)VP < 1.0E-6 torr at 25 C (E) BP > 400 C (E) H < 1.00E-8 (E) POTW removal (%) = 90 via sorption Time for complete ultimate aerobic biodeg > mo Sorption to soils/sediments = v.strong PBT Potential: P3B1 *CEB FATE: Migration to ground water = negl

Health : Health Summary: N ot absorbed through the skin; p oor absorption from the lung and GI tract (analog). Concern for lung toxicity if inhaled based on lung overload for poorly soluble particles ( rat inhalation NOAEL = 10 mg/m3, signs of lung overload at 50 mg/m3) and mutagenicity and respiratory sensitization based on titanium oxide. Uncertain concern for oncogenicity. Test Data: rat 90-day inhalation (90-d holding) N OEL = 2.3 mg/m3, half-life in lungs 2.3 mo
intratracheal instillation, observation for up to 3 months, normal lung architecture at 1 and 3 months after instillation

Ecotox : Test Organism Test Type Test End Point Predicted Measured Comments

fish 96-h LC50 * daphnid 48-h LC50 * green algal 96-h EC50 * fish

_ chronic value * daphnid

_ chronic value *
algal

_ chronic value *
Sewage Sludge 3-h EC50

_ Sewage Sludge

_ Chronic Value _

Ecotox Values Comments: Predictions are based on SARs for Ti oxides; SAR chemical class =Ti oxide; solid with mp = 1300-1350 C (M); S < 0.001 mg/L at 20 C (P); p H7; effective concentrations based on 100% active ingredients and nominal concentrations; hardness <180.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments Assessment Factor 10 Concentration of Concern *( p pb) SARs Ti Oxides SAR Class Insoluble Metal Oxides Ecotox Category N ano; N one
Ecotox Factors Comments:
SAT Chair: L Keifer 564-8916
Exhibit 10.9





Exhibit 10.9




Summary of Director Compensation




Director Fees



The compensation of the Company’s non-employee directors is paid in the form of an annual
retainer, meeting and chair fees and stock-based awards. During 2009 and 2010, the fees that
each non-employee director, Chairman of the Board, lead director, or committee chair, is
entitled to receive are the following:




	 	•	 	An annual retainer of $70,000 (which consisted of $60,000 in cash and $10,000 in
phantom stock units);
	 
	 	•	 	An additional $20,000 retainer for the Chair of the Audit Committee;
	 
	 	•	 	An additional $100,000 retainer for the Interim Non-Executive Chairman of the Board
as of December 10, 2009; prior to that date there was a lead director who was entitled to
$60,000 retainer;
	 
	 	•	 	An additional $20,000 retainer for the Chair of the Compensation Committee;
	 
	 	•	 	An additional $10,000 retainer for the Chair of the Corporate Governance and
Nominating Committee;
	 
	 	•	 	An additional $7,500 retainer for the Chair of the Risk Management Committee;
	 
	 	•	 	An attendance fee of $1,500 for regularly scheduled Board or committee meetings,
other than Audit Committee and Executive Search Committee (which was formed in November
2009) meeting fees which are $2,000 per meeting; and
	 
	 	•	 	An attendance fee of $500 for telephonic special meetings of the Board of Directors.





Option Grants




In 2009, Pinnacle granted to each director who was then serving 15,000 options, which were
granted on the date of the 2009 Annual Meeting of Stockholders. The exercise price for each
option was the closing price of Pinnacle Common Stock on the date of grant. All of the options
vested immediately upon the date of grant. In addition, on the date of the 2009 Annual Meeting
of Stockholders, all prior options granted to the directors vested immediately on such date.